Market Place
Sourcing Support
Gene therapy reduces harmful protein levels in mouse kidneys
29 Oct 2024 //
FIERCE BIOTECH
Purespring Shares Gene Therapy Data for IgA Nephropathy
28 Oct 2024 //
GLOBENEWSWIRE
Purespring Raises £80M In Series B For Kidney Treatments
09 Oct 2024 //
GLOBENEWSWIRE
Purespring bottles up $105M series B for kidney gene therapy
08 Oct 2024 //
FIERCE BIOTECH
Purespring Therapeutics presents preclinical data at the 61st ERA Congress
24 May 2024 //
GLOBENEWSWIRE
Purespring appoints Fredrik Erlandsson as Chief Medical Officer
06 Sep 2023 //
GLOBENEWSWIRE
Purespring Therapeutics appoints Sachin Kelkar as CFO & Julian Hanak as CEO
02 Aug 2023 //
GLOBENEWSWIRE
Charles River & Purespring Announce Gene Therapy Manufacturing Collaboration
16 Feb 2023 //
BUSINESSWIRE
Purespring Therapeutics strengthens scientific leadership with the appointment
07 Sep 2022 //
GLOBENEWSWIRE
Purespring Therapeutics Expands Senior Team with Key Appointments
26 Jul 2022 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.